KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Oscar Health (OSCR) EPS (Weighted Average and Diluted) (2020 - 2025)

Oscar Health's EPS (Weighted Average and Diluted) history spans 6 years, with the latest figure at -$1.34 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) fell 143.64% year-over-year to -$1.34; the TTM value through Dec 2025 reached -$1.84, down 3780.0%, while the annual FY2025 figure was -$1.69, 1790.0% down from the prior year.
  • EPS (Weighted Average and Diluted) reached -$1.34 in Q4 2025 per OSCR's latest filing, down from -$0.53 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.92 in Q1 2025 to a low of -$1.34 in Q4 2025.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.46, with a median of -$0.53 recorded in 2022.
  • Peak YoY movement for EPS (Weighted Average and Diluted): soared 444.44% in 2024, then plummeted 545.0% in 2025.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.98 in 2021, then fell by 7.14% to -$1.05 in 2022, then surged by 36.19% to -$0.67 in 2023, then grew by 17.91% to -$0.55 in 2024, then tumbled by 143.64% to -$1.34 in 2025.
  • Per Business Quant, the three most recent readings for OSCR's EPS (Weighted Average and Diluted) are -$1.34 (Q4 2025), -$0.53 (Q3 2025), and -$0.89 (Q2 2025).